Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Jerome

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Psychopharmacology (Oxford, England)|June 22, 2017
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapyMark T Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Psychopharmacology|June 6, 2020
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trialsLisa Jerome, Allison A Feduccia, Julie B Wang, et al.
Psychopharmacology|September 10, 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot studyAlicia L Danforth, Charles S Grob, Christopher Struble, et al.
Psychopharmacology|August 10, 2024
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trialsLisa Jerome, Allison A Feduccia, Julie B Wang, et al.
Journal of Traumatic Stress|February 20, 2020
Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress DisorderIngmar Gorman, Alexander B Belser, Lisa Jerome, et al.
Psychopharmacology|May 9, 2019
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Psychopharmacology|August 10, 2024
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Psychopharmacology (Oxford, England)|June 22, 2017
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapyMark T Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Psychopharmacology|June 6, 2020
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trialsLisa Jerome, Allison A Feduccia, Julie B Wang, et al.
Psychopharmacology|September 10, 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot studyAlicia L Danforth, Charles S Grob, Christopher Struble, et al.
Psychopharmacology|August 10, 2024
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trialsLisa Jerome, Allison A Feduccia, Julie B Wang, et al.
Journal of Traumatic Stress|February 20, 2020
Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress DisorderIngmar Gorman, Alexander B Belser, Lisa Jerome, et al.
Psychopharmacology|May 9, 2019
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Psychopharmacology|August 10, 2024
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Pageof 4